Showing 1271-1280 of 3308 results for "".
Beware the Quicksand of FOMO
https://practicaldermatology.com/topics/practice-management/beware-the-quicksand-of-fomo/20731/Diverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
https://practicaldermatology.com/issues/april-2024/il23_biologics_in_psoriasis/24457/Christopher Bunick, MD, PhD, discusses a study that explores the structural basis of IL-23 targeted biologic therapies for psoriasis. By mapping the binding sites of these therapies on the IL-23 molecule and correlating molecular properties with clinical efficacy, the study offers insights into whyThe Women's Dermatologic Society Takes Manhattan
https://practicaldermatology.com/topics/practice-management/the-womens-dermatologic-society-takes-manhattan/20579/WDS leaders educate the media on at-home beauty devices, pigment disorders, and more.New Products/New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-otc-7/23287/Just Take a Knee and Sit this One Out
https://practicaldermatology.com/topics/practice-management/just-take-a-knee-and-sit-this-one-out/20569/Who Do We Turn to Now?
https://practicaldermatology.com/topics/practice-management/who-do-we-turn-to-now/21169/“Skin May Be Deep, But Dermatologists Are Superficial…”
https://practicaldermatology.com/topics/general-topics/skin-may-be-deep-but-dermatologists-are-superficial/21254/Why Consider Lasers?
https://practicaldermatology.com/topics/practice-management/why-consider-lasers/18863/Should younger dermatologists add devices to their practice? Laser expert Eric Bernstein, MD talks about the decision to embrace technology and explains how it can mold the future of those who have a passion for lasers and other energy-based devices. Watch other PD Asks videos with Eric BernsteinI knew I wanted to become a dermatologist when...
https://practicaldermatology.com/topics/practice-management/i-knew-i-wanted-to-become-a-dermatologist-when---opefutim/18682/PD Asks: When Yolanda Lenzy, MD was about 13 years old she visited the office of Dr. Lynn McKinley Grant in Washington, DC. It was her first experience with an African American physician, and Dr. Lenzy describes how Dr. McKinley Grant inspired and supported her aspirations. Watch other responses toDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)